TNXP TONIX PHARMACEUTICALS HOLDING CORP US FDA Inspections 8-K Filing 2024 - FDA Fast Track Designation for Tonmya in Fibromyalgia Management Tonix Pharmaceuticals announced that the FDA granted Fast Track designation to its Tonmya product candidate for the management of fibromyalgia.Get access to all SEC 8-K filings of the TONIX PHARMACEUTICALS HOLDING CORP